Bronchodilation and bronchoconstriction: Predictors of future lung function in childhood asthma

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 6, 2006, Pages 1264-1271

  Tantisira, Kelan G ^a,b,c   Fuhlbrigge, Anne L ^a,b   Tonascia, James ^d   Van Natta, Mark ^d   Zeiger, Robert S ^e,f   Strunk, Robert C ^g   Szefler, Stanley J ^h   Weiss, Scott T ^a  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e KAISER PERMANENTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

asthma; bronchodilator; corticosteroid; FEV 1; methacholine; natural history; PC 20

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; NEDOCROMIL; PLACEBO; SALBUTAMOL;

AIRWAY; ALLERGIC ASTHMA; ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CHILD; CHILDHOOD; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VITAL CAPACITY;

ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUNG; MALE; MULTICENTER STUDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATORY FUNCTION TESTS;

EID: 33646943565     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.050     Document Type: Article

References (42)

1. Mannino D.M., Homa D.M., Akinbami L.J., Moorman J.E., Gwynn C., and Redd S.C. Surveillance for asthma: United States, 1980-1999. MMWR Surveill Summ 51 (2002) 1-13
2. Blair H. Natural history of childhood asthma: 20-year follow-up. Arch Dis Child 52 (1977) 613-619
3. Martin A.J., McLennan L.A., Landau L.I., and Phelan P.D. The natural history of childhood asthma to adult life. BMJ 280 (1980) 1397-1400
4. Gerritsen J., Koeter G.H., Postma D.S., Schouten J.P., and Knol K. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 140 (1989) 1325-1330
5. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor D.R., Flannery E.M., et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 (2003) 1414-1422
6. Ulrik C.S., Backer V., Dirksen A., Pedersen M., and Koch C. Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up. Respir Med 89 (1995) 547-554
7. Kitch B.T., Paltiel A.D., Kuntz K.M., Dockery D.W., Schouten J.P., Weiss S.T., et al. A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Chest 126 (2004) 1875-1882
8. Fuhlbrigge A.L., Kitch B.T., Paltiel A.D., Kuntz K.M., Neumann P.J., Dockery D.W., et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 107 (2001) 61-67
9. in't Veen J.C., Smits H.H., Hiemstra P.S., Zwinderman A.E., Sterk P.J., and Bel E.H. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 160 (1999) 93-99
10. National Asthma Education and Prevention Program Expert Panel. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institute of Health Publications, publication number 97-4051, 1997.
11. Ulrik C.S. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 13 (1999) 904-918
12. Godden D.J., Ross S., Abdalla M., McMurray D., Douglas A., Oldman D., et al. Outcome of wheeze in childhood: symptoms and pulmonary function 25 years later. Am J Respir Crit Care Med 149 (1994) 106-112
13. Oswald H., Phelan P.D., Lanigan A., Hibbert M., Carlin J.B., Bowes G., et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 23 (1997) 14-20
14. Grol M.H., Gerritsen J., Vonk J.M., Schouten J.P., Koeter G.H., Rijcken B., et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years: a 30-year follow-up study. Am J Respir Crit Care Med 160 (1999) 1830-1837
15. Roorda R.J., Gerritsen J., van Aalderen W.M., Schouten J.P., Veltman J.C., Weiss S.T., et al. Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 93 (1994) 575-584
16. Van Schayck C.P., Dompeling E., Van Herwaarden C.L., Wever A.M., and Van Weel C. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 144 (1991) 1297-1301
17. Xuan W., Peat J.K., Toelle B.G., Marks G.B., Berry G., and Woolcock A.J. Lung function growth and its relation to airway hyperresponsiveness and recent wheeze: results from a longitudinal population study. Am J Respir Crit Care Med 161 (2000) 1820-1824
18. Rasmussen F., Taylor D.R., Flannery E.M., Cowan J.O., Greene J.M., Herbison G.P., et al. Outcome in adulthood of asymptomatic airway hyperresponsiveness in childhood: a longitudinal population study. Pediatr Pulmonol 34 (2002) 164-171
19. Postma D.S., de Vries K., Koeter G.H., and Sluiter H.J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis 134 (1986) 276-280
20. Postma D.S., and Sluiter H.J. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 140 (1989) S100-S105
21. Kjellman B., and Hesselmar B. Prognosis of asthma in children: a cohort study into adulthood. Acta Paediatr 83 (1994) 854-861
22. Anderson G.P. Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. Am J Respir Crit Care Med 161 (2000) S188-S196
23. Roth M., Johnson P.R., Rudiger J.J., King G.G., Ge Q., Burgess J.K., et al. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360 (2002) 1293-1299
24. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. Control Clin Trials 20 (1999) 91-120
25. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 343 (2000) 1054-1063
26. Coultas D.B., Howard C.A., Skipper B.J., and Samet J.M. Spirometric prediction equations for Hispanic children and adults in New Mexico. Am Rev Respir Dis 138 (1988) 1386-1392
27. Knudson R.J., Lebowitz M.D., Holberg C.J., and Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127 (1983) 725-734
28. Strunk R.C., Szefler S.J., Phillips B.R., Zeiger R.S., Chinchilli V.M., Larsen G., et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 112 (2003) 883-892
29. Schuh S., Reisman J., Alshehri M., Dupuis A., Corey M., Arseneault R., et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 343 (2000) 689-694
30. Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. Chapter 12: regression diagnostics. In: Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. (Eds). Applied regression analysis and other multivariable methods. 3rd ed. (1998), Brooks/Cole, Pacific Grove 212-280
31. Weiss S.T., Van Natta M.L., and Zeiger R.S. Relationship between increased airway responsiveness and asthma severity in the Childhood Asthma Management Program. Am J Respir Crit Care Med 162 (2000) 50-56
32. Ulrik C.S. Factors associated with increased bronchial responsiveness in adolescents and young adults: the importance of adjustment for prechallenge FEV1. J Allergy Clin Immunol 97 (1996) 761-767
33. Douma W.R., de Gooijer A., Rijcken B., Schouten J.P., Koeter G.H., Weiss S.T., et al. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study. Eur Respir J 10 (1997) 2772-2777
34. Postma D.S., de Graaf-Breederveld N., Koeter G.H., and Sluiter H.J. The relationship between reversibility and hyperreactivity. Eur Respir J 1 (1988) 483-485
35. Ramsdell J.W., Nachtwey F.J., and Moser K.M. Bronchial hyperreactivity in chronic obstructive bronchitis. Am Rev Respir Dis 126 (1982) 829-832
36. Szefler S.J., Martin R.J., King T.S., Boushey H.A., Cherniack R.M., Chinchilli V.M., et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109 (2002) 410-418
37. Kerstjens H.A., Overbeek S.E., Schouten J.P., Brand P.L., and Postma D.S. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J 6 (1993) 868-876
38. Szefler S.J., Phillips B.R., Martinez F.D., Chinchilli V.M., Lemanske R.F., Strunk R.C., et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 117 (2006) 45-52
39. Dixon A.E., and Irvin C.G. Early intervention of therapy in asthma. Curr Opin Pulm Med 11 (2005) 51-55
40. Djukanovic R. Airway inflammation in asthma and its consequences: implications for treatment in children and adults. J Allergy Clin Immunol 109 (2002) S539-S548
41. Faul J.L., Demers E.A., Burke C.M., and Poulter L.W. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma. Chest 121 (2002) 1414-1420
42. Covar R.A., Spahn J.D., Murphy J.R., and Szefler S.J. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 170 (2004) 234-241